Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-19T06:28:36.309Z Has data issue: false hasContentIssue false
  • English
  • Français

Monochlorimipramine: A Controlled Trial of a New Antidepressant

Published online by Cambridge University Press:  29 January 2018

M. Harvey Symes
M. Harvey Symes*
Affiliation:
112, The Drive, Hove, Sussex
Get access Rights & Permissions [Opens in a new window]

Extract

In view of the structural similarity of imipramine and promazine, an attempt has been made to obtain a stronger anti-depressive effect by means of chlorination of imipramine at the same place in the molecule. Brandner (1964) has described the results of mono-chlorimipi-amine (MCI) administration in a series of 25 cases of various kinds of depression.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 113 , Issue 499 , June 1967 , pp. 671 - 672
Copyright
Copyright © Royal College of Psychiatrists, 1967 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brandner, M. (1964). Schweiz. Arch. Neurol. Psychiat., 93, 137.Google Scholar
Hamilton, M. (1960). J. Neurol. Neurosurg. Psychiat., 23, 56.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.